Population Pharmacokinetics of Monalizumab in Patients With Advanced Solid Tumors

Hwang, M; Fan, CL; Yue, MS; Zhou, DS; Paturel, C; Andre, P; Cheng, LY; Mitchell, P; Kourtesis, P; Ruscica, D; Das, M; Morsli, N; Ren, S; Gibbs, M; Phipps, A; Song, XY

Song, XY (通讯作者),AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878 USA.

JOURNAL OF CLINICAL PHARMACOLOGY, 2023; 63 (7): 817

Abstract

Monalizumab is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NK......

Full Text Link